| Carmen GarcĂa |
5 years ago |
Product Hunt |
|
https://www.producthunt.com/posts/massive-bio |
| Carmen GarcĂa |
5 years ago |
Description |
Massive Bio’s mission is to provide access to clinical trials for every cancer patient regardless of his/her location and/or financial stability. Massive Bio is an AI-driven platform connecting cancer patients and their oncologists to bio-pharmaceutical clinical trials, yielding a profound improvement in access and match rates, leading to faster drug development timelines, and creating a novel oncology data ecosystem for improved protocol design and real-world insights. |
Massive Bio’s mission is to provide access to clinical trials for every cancer patient regardless of his/her location and/or financial stability. Massive Bio is an AI-driven platform connecting cancer patients and their oncologists to bio-pharmaceutical clinical trials, yielding a profound improvement in access and match rates, leading to faster drug development timelines, and creating a novel oncology data ecosystem for improved protocol design and real-world insights.
Massive Bio controls the patient enrollment value chain starting with patient identification, following with AI-based virtual pre-screening outside the site, and resolving last mile issues for clinical trial enrollment. While improving cancer patients' lives, Massive Bio serves close to two dozen pharmaceutical companies, contract research organizations (CROs), and hospital networks.
In addition, Massive Bio has been awarded an SBIR contract by the National Cancer Institute (NCI) to develop and characterize it's Deep Learning Clinical Trial Matching System (DLCTMS), Contract No. 75N91020C00016. Massive Bio provides oncology dedicated patient recruitment, site selection, real-world data services, and AI-based trial pre-screening services to its enterprise customers. Massive Bio was founded in 2015, is headquartered in NYC, and is privately funded by strategic and financial investors. |
| Carmen GarcĂa |
5 years ago |
Screenshot |
|
 |
| Carmen GarcĂa |
5 years ago |
Logo |
 |
 |
| Carmen GarcĂa |
5 years ago |
LinkedIn |
|
massive-bio |
| Carmen GarcĂa |
5 years ago |
Twitter |
massivebio |
MassiveBio |
| Carmen GarcĂa |
5 years ago |
Description |
Massive Bio’s mission is to provide access to clinical trials for every cancer patient regardless of his/her location and/or financial stability. Massive Bio is an AI-driven platform connecting cancer patients and their oncologists to bio-pharmaceutical clinical trials, yielding profound improvement in access and match rates, leading to faster drug development timelines, and creating a novel oncology data ecosystem for improved protocol design and real-world insights. Massive Bio controls the patient enrollment value chain starting with patient identification, following with AI-based virtual pre-screening outside the site, and resolving last mile issues for clinical trial enrollment. While improving cancer patients lives, Massive Bio serves close to two dozen pharmaceutical companies, contract research organizations (CROs) and hospital networks. In addition, Massive Bio has been awarded an SBIR contract by the National Cancer Institute (NCI) to develop and characterize its Deep Learning Clinical Trial Matching System (DLCTMS), Contract No. 75N91020C00016. Massive Bio provides oncology dedicated patient recruitment, site selection, real-world data services, and AI-based trial prescreening services to its enterprise customers. Massive Bio was founded in 2015, is headquartered in NYC, and is privately funded by strategic and financial investors. |
Massive Bio’s mission is to provide access to clinical trials for every cancer patient regardless of his/her location and/or financial stability. Massive Bio is an AI-driven platform connecting cancer patients and their oncologists to bio-pharmaceutical clinical trials, yielding a profound improvement in access and match rates, leading to faster drug development timelines, and creating a novel oncology data ecosystem for improved protocol design and real-world insights. |
| Carmen GarcĂa |
5 years ago |
Address |
90 West St |
90 West Street |
| Carmen GarcĂa |
5 years ago |
Phrase |
Your Clinical Trial Partner |
Your clinical trial partner |
| Massive Bio, Inc. |
5 years ago |
Android App |
|
https://play.google.com/store/apps/details?id=com.massivebio.massivebio |
| Massive Bio, Inc. |
5 years ago |
Business Model Type |
|
Data |
| Massive Bio, Inc. |
5 years ago |
State Status |
Unknown |
Growing |
| Massive Bio, Inc. |
5 years ago |
Phrase |
AI powered oncology platform |
Your Clinical Trial Partner |
| Massive Bio, Inc. |
5 years ago |
City |
|
New York |
| Massive Bio, Inc. |
5 years ago |
Address |
|
90 West St |
| Massive Bio, Inc. |
5 years ago |
Postal Code |
|
10006 |
| Massive Bio, Inc. |
5 years ago |
Description |
Massive Bio is an AI-driven platform connecting cancer patients and their oncologists to bio-pharmaceutical clinical trials that offer new, alternative, and targeted treatments to help create positive patient outcomes. |
Massive Bio’s mission is to provide access to clinical trials for every cancer patient regardless of his/her location and/or financial stability. Massive Bio is an AI-driven platform connecting cancer patients and their oncologists to bio-pharmaceutical clinical trials, yielding profound improvement in access and match rates, leading to faster drug development timelines, and creating a novel oncology data ecosystem for improved protocol design and real-world insights. Massive Bio controls the patient enrollment value chain starting with patient identification, following with AI-based virtual pre-screening outside the site, and resolving last mile issues for clinical trial enrollment. While improving cancer patients lives, Massive Bio serves close to two dozen pharmaceutical companies, contract research organizations (CROs) and hospital networks. In addition, Massive Bio has been awarded an SBIR contract by the National Cancer Institute (NCI) to develop and characterize its Deep Learning Clinical Trial Matching System (DLCTMS), Contract No. 75N91020C00016. Massive Bio provides oncology dedicated patient recruitment, site selection, real-world data services, and AI-based trial prescreening services to its enterprise customers. Massive Bio was founded in 2015, is headquartered in NYC, and is privately funded by strategic and financial investors. |
| Massive Bio, Inc. |
5 years ago |
iOS App |
|
https://apps.apple.com/us/app/synergy-ai-cancer-trial-finder/id1525463521 |
| Massive Bio, Inc. |
5 years ago |
Video URL |
https://www.youtube.com/channel/UCQFZEnq6kbKdjqYvXOkRxJQ |
https://www.youtube.com/watch?v=8Xsq9ekDLzw |
| Massive Bio, Inc. |
5 years ago |
Video Channel URL |
|
https://www.youtube.com/channel/UCQFZEnq6kbKdjqYvXOkRxJQ |
| Massive Bio, Inc. |
5 years ago |
Tags |
- Artificial Intelligence
- Clinical Trials
- Cancer
- Treatments
- Biotechnology
|
- Artificial Intelligence
- Clinical Trials
- Cancer
- Biotechnology
- Patient
- Pharmaceutical
|
| Massive Bio, Inc. |
5 years ago |
Competitors |
|
- Antidote.me
- Tempus
- Flatiron Health
- myTomorrows
- 23andMe
- PatientsLikeMe
|
| Massive Bio, Inc. |
5 years ago |
Tags |
|
- Artificial Intelligence
- Clinical Trials
- Cancer
- Treatments
- Biotechnology
|
| Massive Bio, Inc. |
5 years ago |
Contact Phone |
|
(917) 336-3319 |
| Massive Bio, Inc. |
5 years ago |
Contact E-mail |
|
[email protected] |
| Massive Bio, Inc. |
5 years ago |
Video URL |
|
https://www.youtube.com/channel/UCQFZEnq6kbKdjqYvXOkRxJQ |
| Massive Bio, Inc. |
5 years ago |
Description |
|
Massive Bio is an AI-driven platform connecting cancer patients and their oncologists to bio-pharmaceutical clinical trials that offer new, alternative, and targeted treatments to help create positive patient outcomes. |
| Massive Bio, Inc. |
5 years ago |
State |
|
New York |
| Massive Bio, Inc. |
5 years ago |
Type |
|
Startup |
| Massive Bio, Inc. |
5 years ago |
Business Type |
|
B2C (Business to Customer) |
| Massive Bio, Inc. |
5 years ago |
Industry |
|
Healthcare Equipment & Services |
| Massive Bio, Inc. |
5 years ago |
State Status |
|
Unknown |
| Massive Bio, Inc. |
5 years ago |
Employees Number |
|
26 - 50 |
| Massive Bio, Inc. |
5 years ago |
Name |
|
Massive Bio |
| Massive Bio, Inc. |
5 years ago |
Legal Name |
|
Massive Bio, Inc. |
| Massive Bio, Inc. |
5 years ago |
Phrase |
|
AI powered oncology platform |
| Massive Bio, Inc. |
5 years ago |
Country |
|
United States |
| Massive Bio, Inc. |
5 years ago |
Date Founded |
|
2015-05-04 |
| Massive Bio, Inc. |
5 years ago |
URL |
|
massivebio.com |
| Massive Bio, Inc. |
5 years ago |
Blog URL |
|
https://massivebio.com/cancer-blog |
| Massive Bio, Inc. |
5 years ago |
Facebook |
|
massivebio |
| Massive Bio, Inc. |
5 years ago |
Twitter |
|
massivebio |
| Massive Bio, Inc. |
5 years ago |
AngelList |
|
company/massive-bio |
| Massive Bio, Inc. |
5 years ago |
CrunchBase |
|
massivebio |
| Massive Bio, Inc. |
5 years ago |
Logo |
|
 |